☰

Mark Robertson-Tessi, Ph.D. - Publications

Affiliations: 
2010 Applied Mathematics University of Arizona, Tucson, AZ 
Area:
Applied Mathematics, Oncology, Immunology
Tree Info Similar researchers PubMed Report error

26 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2022 Strobl MAR, Gallaher J, West J, Robertson-Tessi M, Maini PK, Anderson ARA. Spatial structure impacts adaptive therapy by shaping intra-tumoral competition. Communications Medicine. 2: 46. PMID 35603284 DOI: 10.1038/s43856-022-00110-x  0.338
2022 Gatenbee CD, Baker AM, Schenck RO, Strobl M, West J, Neves MP, Hasan SY, Lakatos E, Martinez P, Cross WCH, Jansen M, Rodriguez-Justo M, Whelan CJ, Sottoriva A, Leedham S, ... Robertson-Tessi M, et al. Immunosuppressive niche engineering at the onset of human colorectal cancer. Nature Communications. 13: 1798. PMID 35379804 DOI: 10.1038/s41467-022-29027-8  0.446
2021 West J, Schenck RO, Gatenbee C, Robertson-Tessi M, Anderson ARA. Normal tissue architecture determines the evolutionary course of cancer. Nature Communications. 12: 2060. PMID 33824323 DOI: 10.1038/s41467-021-22123-1  0.371
2020 Strobl MAR, West J, Viossat Y, Damaghi M, Robertson-Tessi M, Brown JS, Gatenby RA, Maini PK, Anderson ARA. Turnover modulates the need for a cost of resistance in adaptive therapy. Cancer Research. PMID 33172930 DOI: 10.1158/0008-5472.CAN-20-0806  0.344
2020 Park DS, Luddy KA, Robertson-Tessi M, O'Farrelly C, Gatenby RA, Anderson ARA. Searching for Goldilocks: How evolution and ecology can help uncover more effective patient-specific chemotherapies. Cancer Research. PMID 32934022 DOI: 10.1158/0008-5472.Can-19-3981  0.362
2020 Lakatos E, Williams MJ, Schenck RO, Cross WCH, Househam J, Zapata L, Werner B, Gatenbee C, Robertson-Tessi M, Barnes CP, Anderson ARA, Sottoriva A, Graham TA. Evolutionary dynamics of neoantigens in growing tumors. Nature Genetics. PMID 32929288 DOI: 10.1038/S41588-020-0687-1  0.521
2019 Nichol D, Robertson-Tessi M, Anderson ARA, Jeavons P. Model genotype-phenotype mappings and the algorithmic structure of evolution. Journal of the Royal Society, Interface. 16: 20190332. PMID 31690233 DOI: 10.1098/Rsif.2019.0332  0.327
2019 Park DS, Robertson-Tessi M, Luddy KA, Maini PK, Bonsall MB, Gatenby RA, Anderson ARA. The Goldilocks Window of Personalized Chemotherapy: Getting the Immune Response Just Right. Cancer Research. PMID 31387920 DOI: 10.1158/0008-5472.Can-18-3712  0.558
2019 Robertson-Tessi M, El-Kareh A, Goriely A. Corrigendum to ``A model for effects of adaptive immunity on tumor response to chemotherapy and chemoimmunotherapy'' [Journal of Theoretical Biology 380 (2015) 569-584]. Journal of Theoretical Biology. 464: 181. PMID 30610835 DOI: 10.1016/J.Jtbi.2018.12.040  0.648
2019 Robertson-Tessi M, El-Kareh A, Goriely A. Corrigendum to ``A mathematical model of tumor-immune interactions'' [Journal of Theoretical Biology 294 (2012) 56-73]. Journal of Theoretical Biology. 464: 180. PMID 30610834 DOI: 10.1016/J.Jtbi.2018.12.041  0.637
2019 Kim E, Gallaher J, Robertson-Tessi M, Smalley I, Gatenby R, Smalley K, Zhang J, Eroglu Z, Anderson ARA. Abstract SY38-02: Personalized adaptive therapy for metastatic cancer: An integrated approach Cancer Research. 79. DOI: 10.1158/1538-7445.Am2019-Sy38-02  0.506
2018 Mailloux AW, Rana F, Yagawa Y, Robertson-Tessi M, Susan ZL, Anderson ARA, Mulé JJ. Abstract B17: A dual in vivo and in silico system to model ectopic lymph node structure formation and antitumor immune response in the murine tumor microenvironment Cancer Research. 78. DOI: 10.1158/1538-7445.Mousemodels17-B17  0.607
2017 Yagawa Y, Robertson-Tessi M, Zhou SL, Anderson ARA, Mulé JJ, Mailloux AW. Systematic Screening of Chemokines to Identify Candidates to Model and Create Ectopic Lymph Node Structures for Cancer Immunotherapy. Scientific Reports. 7: 15996. PMID 29167448 DOI: 10.1038/S41598-017-15924-2  0.522
2017 Ibrahim-Hashim A, Robertson-Tessi M, Enrizues-Navas P, Damaghi M, Balagurunathan Y, Wojtkowiak JW, Russell S, Yoonseok K, Lloyd MC, Bui MM, Brown JS, Anderson AR, Gillies RJ, Gatenby RA. Defining cancer subpopulations by adaptive strategies rather than molecular properties provides novel insights into intratumoral evolution. Cancer Research. PMID 28249898 DOI: 10.1158/0008-5472.Can-16-2844  0.487
2016 Poleszczuk J, Luddy KA, Prokopiou S, Robertson-Tessi M, Moros EG, Fishman M, Djeu JY, Finkelstein SE, Enderling H. Abscopal benefits of localized radiotherapy depend on activated T cell trafficking and distribution between metastatic lesions. Cancer Research. PMID 26833128 DOI: 10.1158/0008-5472.Can-15-1423  0.52
2015 Robertson-Tessi M, El-Kareh A, Goriely A. A model for effects of adaptive immunity on tumor response to chemotherapy and chemoimmunotherapy. Journal of Theoretical Biology. 380: 569-84. PMID 26087282 DOI: 10.1016/J.Jtbi.2015.06.009  0.674
2015 Robertson-Tessi M, Gillies RJ, Gatenby RA, Anderson AR. Impact of metabolic heterogeneity on tumor growth, invasion, and treatment outcomes. Cancer Research. 75: 1567-79. PMID 25878146 DOI: 10.1158/0008-5472.Can-14-1428  0.563
2015 Robertson-Tessi M, Anderson AR. Big Bang and context-driven collapse. Nature Genetics. 47: 196-7. PMID 25711865 DOI: 10.1038/Ng.3231  0.377
2015 Robertson-Tessi M, Park D, Luddy K, Mailloux A, Burnette PK, Anderson A. Abstract A86: Harnessing T-cell homeostasis to diagnose and treat solid and liquid tumors Cancer Immunology Research. 3. DOI: 10.1158/2326-6074.Tumimm14-A86  0.511
2015 Prokopiou S, Poleszczuk J, Robertson-Tessi M, Luddy KA, Fishman M, Moros E, Djeu JY, Enderling H. Abstract A19: Systems biology approach predicts the diagnostic value of T effector: T regulatory cell ratio in clinical response to combined radiation/immunotherapy of high-risk soft tissue sarcoma Cancer Immunology Research. 3. DOI: 10.1158/2326-6074.Tumimm14-A19  0.568
2015 Poleszczuk J, Prokopiou S, Robertson-Tessi M, Luddy K, Moros E, Fishman M, Djeu J, Enderling H. Abstract A18: A systems biology approach to predict immunotherapy augmented abscopal effects Cancer Immunology Research. 3. DOI: 10.1158/2326-6074.Tumimm14-A18  0.556
2015 Robertson-Tessi M, Gillies RJ, Gatenby RA, Anderson AR. Abstract B05: Harnessing heterogeneity to design better combination therapies Cancer Research. 75. DOI: 10.1158/1538-7445.Chtme14-B05  0.57
2014 Luddy KA, Robertson-Tessi M, Tafreshi NK, Soliman H, Morse DL. The role of toll-like receptors in colorectal cancer progression: evidence for epithelial to leucocytic transition. Frontiers in Immunology. 5: 429. PMID 25368611 DOI: 10.3389/Fimmu.2014.00429  0.539
2013 Robertson-Tessi M, Gillies RJ, Gatenby RA, Anderson ARA. Abstract A2: The importance of metabolic heterogeneity and its consequences on tumor invasion, metastatic growth, and treatment Cancer Research. 73. DOI: 10.1158/1538-7445.Tim2013-A2  0.544
2012 Robertson-Tessi M, El-Kareh A, Goriely A. A mathematical model of tumor-immune interactions. Journal of Theoretical Biology. 294: 56-73. PMID 22051568 DOI: 10.1016/J.Jtbi.2011.10.027  0.665
2011 Robertson-Tessi M, Estrella VC, Chen T, Lloyd MC, Gillies RJ, Gatenby RA, Anderson ARA. Abstract 53: Exploiting heterogeneity to develop better treatment strategies using an evolutionary multiscale mathematical model of tumor-vessel interactions Cancer Research. 71: 53-53. DOI: 10.1158/1538-7445.Am2011-53  0.591
Show low-probability matches.